Skip to main content
CRSP
NASDAQ Life Sciences

CTX310 Cuts Triglycerides 63% at Day 30, Beating Analyst Expectations

Tom Rudovsky · Reported by Benzinga
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$45.475
Mkt Cap
$4.411B
52W Low
$44.12
52W High
$63.45
52W Position info
3.1% above low
Off High info
28% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

CRSP is trading near its 52-week low of $44.12 (3.1% above the low).

Summary

CRISPR presented Phase 1b data at AHA showing a single course of CTX310 cut mean triglycerides 63% and ANGPTL3 65% at Day 30 in 10 patients with severe hypertriglyceridemia, with median baseline triglycerides above 1,000 mg/dL. The fuller dataset adds a 51% mean drop in non-HDL-C, 23% in ApoB and 16% in LDL-C, and reductions persisted in patients followed at least 90 days. Safety was clean: no serious adverse events, no Grade 3 or higher treatment-related events, no clinically relevant liver enzyme elevations, and zero acute pancreatitis cases even though 30% of enrollees had prior history. William Blair said the 63% triglyceride reduction beat its roughly 50% expectation and reiterated Outperform, noting RMAT designations in sHTG and elevated LDL-C give the program preliminary regulatory buy-in. Despite that, shares fell 8.17% to $45.95, near the 52-week low of $44.12 — the market is not paying for the data. Additional Phase 1b cohorts are still recruiting.

At the time of this announcement, CRSP was trading at $45.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $44.12 to $63.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

CRSP - Latest Insights

CRSP
Nov 09, 2026, 9:16 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $50.42
Real-time Price: $45.54 info
Change: -$4.88 (-10%) info
Market Cap: $4.38B info
CRSP
Nov 02, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $49.98
Real-time Price: $45.54 info
Change: -$4.44 (-9%) info
Market Cap: $4.38B info
CRSP
Nov 02, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $49.01
Real-time Price: $45.54 info
Change: -$3.47 (-7%) info
Market Cap: $4.38B info
CRSP
Nov 02, 2026, 4:06 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $49.01
Real-time Price: $45.54 info
Change: -$3.47 (-7%) info
Market Cap: $4.38B info
CRSP
Oct 19, 2026, 4:30 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $49.00
Real-time Price: $45.54 info
Change: -$3.46 (-7%) info
Market Cap: $4.38B info